Faceland, a leading medical aesthetics clinic chain, has acquired a majority stake in Italian network Juneco, aiming to expand its presence in Europe and enhance access to high-quality cosmetic medicine.
Information on the Target
Faceland, founded in 2013 in the Netherlands, is a prominent chain of branded medical aesthetics clinics with a robust presence in the Netherlands, Belgium, Germany, and Switzerland. The company offers clinically validated medical aesthetics treatments at competitive price points, ensuring accessibility for patients through clinics operated by qualified medical professionals. These professionals receive specialized training via Faceland's proprietary training academy. With a vision to transform cosmetic medicine into a mainstream healthcare option, Faceland has grown rapidly, boasting 35 clinics across Europe.
In a strategic move to enhance its market footprint, Faceland has announced its acquisition of a majority stake in Juneco, Italy's leading medical aesthetics network established in 2017. This acquisition will significantly expand Faceland's operations by adding Italy, the fourth-largest medical aesthetics market in Europe, to its portfolio. Together, the two entities aim to operate over 50 clinics across Europe by the end of the year.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Italy
The medical aesthetics industry in Italy has experienced significant growth over the past few years, driven by increasing consumer demand for non-invasive and minimally invasive procedures. This surge reflects a broader trend in Europe, where aesthetic treatm
Similar Deals
Engineering → OPOH - One Person One Health
2025
Lupin Ltd. → Bausch VISUfarma Pharma’s ophthalmology portfolio
2025
Lifenet Healthcare → Cab Polidiagnostico
2023
Funecap Funeral Service → Centro Funerario Bergamasco
2023
Faceland
invested in
Juneco
in 2024
in a Other deal